# SCOTUS to Rule on Marijuana Users and Gun Ownership Rights > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/marijuana-users-gun-ownership-scotus-case/ > **Published:** 2026-04-24T13:30:43-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:12:07-04:00 > **Clinical Summary:** The Supreme Court reviews marijuana users gun ownership rights, impacting federal law and patient safety in cannabis medicine. --- ✦ New CED Clinical Relevance #50 [Clinical Context](https://cedclinic.com/cannabis-hyperemesis-syndrome-treatment-insights-2026/) Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicySafetyMental Health Clinical Summary The U.S. Supreme Court has agreed to hear a case that will determine whether federal law can prohibit firearm ownership for marijuana users, a ruling that could have significant implications for patient safety, clinical documentation, and legal liability. Currently, federal law prohibits any unlawful drug user from possessing firearms, and marijuana remains a Schedule I controlled substance federally despite state-level legalization in many jurisdictions. This legal ambiguity creates a complex situation for clinicians who document [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in medical records, as such documentation could theoretically be used to deny patients their Second Amendment rights or subject them to legal consequences. For patients who use cannabis legally under state law, the court’s decision will clarify their constitutional rights and may affect their willingness to disclose cannabis use to healthcare providers. The ruling will also influence how clinicians document substance use and how thoroughly they counsel patients about the legal implications of cannabis use in their jurisdiction. Clinicians should be aware that a SCOTUS decision in either direction may require adjustments to informed consent discussions and may impact patient privacy concerns regarding medical records that document cannabis use. Dr. Caplan’s Take “What the Supreme Court decides about cannabis users and firearm ownership will have real clinical implications for my patients, because right now I’m counseling people on a substance that’s legal in their state but creates a federal firearms prohibition they may not even know about, and that disconnect between state law and federal policy is something we need to resolve clearly so I can give my patients straightforward medical and legal guidance.” Clinical Perspective The Supreme Court’s consideration of whether cannabis users can legally own firearms represents a significant intersection of drug policy, constitutional rights, and [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) that clinicians should understand given its potential impact on [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and disclosure practices. While the case fundamentally addresses Second Amendment rights, it raises important clinical questions about how healthcare providers should counsel patients regarding cannabis use, given that federal law still classifies marijuana as a Schedule I controlled substance despite growing state legalization. Providers should be aware that patients may face legal consequences for cannabis use that extend beyond health implications, which could influence disclosure patterns during history-taking and create tension between confidentiality and federal reporting obligations that vary by jurisdiction. The complexity is further compounded by limited evidence on whether cannabis use itself demonstrates unfitness to own firearms, unlike established risk factors such as active substance use disorders or certain psychiatric conditions. Clinicians should consider discussing these legal and regulatory uncertainties with patients who use cannabis, particularly those asking about health and safety 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+SCOTUS+to+rule+on+whether+%3Cb%3Emarijuana%3C%2Fb%3E+users+can+own+guns+%7C+The+Chicago+Report+-+YouTube+%40drcaplan&url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DYFTlLUriiT0)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DYFTlLUriiT0)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+SCOTUS+to+rule+on+whether+%3Cb%3Emarijuana%3C%2Fb%3E+users+can+own+guns+%7C+The+Chicago+Report+-+YouTube+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DYFTlLUriiT0)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [CED Digest: 436 Items — March 14, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) - [CED Digest: 405 Items — March 12, 2026](https://cedclinic.com/alabama-medical-cannabis-sales-2026-spring-launch/) - [CED Digest: 392 Items — March 11, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) 📰 Source: [https://www.youtube.com/watch?v=YFTlLUriiT0](https://www.youtube.com/watch?v=YFTlLUriiT0) Further Reading Research Digest[Research Digest: 10 Recent Studies – April 22, 2026](https://cedclinic.com/recent-cannabinoid-clinical-research-april-2026/) CED Clinic Blog[Cannabinoids and Chronic Pain: 2025 Evidence Review](https://cedclinic.com/cannabinoids-chronic-pain-clinical-outcomes-2025/) Evidence Watch[Characterizing public comments via Regulations.gov in response to proposed cannabis rescheduling in the United States.](https://cedclinic.com/cannabis-rescheduling-public-comments-analysis-2024/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence Part 2 US Supreme Court marijuana users & their gun rights #supremecourt … – YouTube Watch the continuation of the Supreme Court discussion on marijuana users and their rights to own guns. Watch Now [Supreme Court could loosen law barring marijuana users from owning guns – WTOP News](https://cedclinic.com/cannabis-firearm-ownership-legal-issues-supreme-court-review/) News coverage on the potential Supreme Court decision affecting marijuana users' firearm ownership rights. [Read More](https://cedclinic.com/cannabis-firearm-ownership-legal-issues-supreme-court-review/) [Marijuana Gun Rights Case | U.S. Supreme Court & NC Law](https://cedclinic.com/marijuana-gun-rights-supreme-court-nc-law-update/) An analysis of the marijuana gun rights case and its impact on North Carolina law and beyond. [Learn More](https://cedclinic.com/marijuana-gun-rights-supreme-court-nc-law-update/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).